Antagonistic analogs of growth hormone-releasing hormone increase the efficacy of treatment of triple negative breast cancer in nude mice with doxorubicin; A preclinical study

INTRODUCTION: This study evaluated the effects of an antagonistic analog of growth hormone-releasing hormone, MIA-602, on tumor growth, response to doxorubicin, expression of drug resistance genes, and efflux pump function in human triple negative breast cancers. METHODS: HCC1806 (doxorubicin-sensit...

Descripción completa

Detalles Bibliográficos
Autores principales: Perez, Roberto, Schally, Andrew V, Popovics, Petra, Cai, Renzhi, Sha, Wei, Rincon, Ricardo, Rick, Ferenc G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278278/
https://www.ncbi.nlm.nih.gov/pubmed/25593995

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278278/
https://www.ncbi.nlm.nih.gov/pubmed/25593995

Ejemplares similares